Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).

Journal: Transfusion
PMID:

Abstract

BACKGROUND: Pegfilgrastim is a covalently bound conjugate of filgrastim and mono-methoxypolyethylene glycol with a longer half-life.

Authors

  • Vladan Vucinic
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Madlen Jentzsch
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Sabine Leiblein
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Enrica Bach
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Yvonne Remane
    Leipzig Medical Center, Pharmacy, University Clinic Leipzig, Leipzig, Germany.
  • Kai Schulze-Forster
    CellTrend GmbH, Luckenwalde, Germany.
  • Michael Cross
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Wolfram Pönisch
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Sebastian Schwind
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Georg-Nikolaus Franke
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
  • Uwe Platzbecker
    Medical Clinic and Polyclinic I, University Hospital, Technical University Dresden, Dresden, Germany.
  • Dietger Niederwieser
    Leipzig Medical Center, Clinic for Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.